Members: Dr. Sandra Johnston

Research Scientist

PhD Nursing Science



Dr. Sandra Johnston (PhD Nursing Science) joined the Swanson lab in early 2012 as a research scientist. She brings a wealth of clininical trial and clinical experience to the lab.

Outside of work, Sandra can be found hiking, camping, and gardening.

Sandra is very dedicated to solving the problem of glioma growth and improvement survival.


BS Nursing Truman State University
MS Clinical Nurse Specialty Texas Womans University
PhD Nursing Science University of Washington
PostDoc Fellowship Biomedical and Health Informatics University of Washington


Raizer JJ, Grimm SA, Rademaker A, Chandler JP, Muro K, Helenowski I, Rice L,
McCarthy K, Johnston SK, Mrugala MM, Chamberlain M. A phase II trial of PTK787/ZK
222584 in recurrent or progressive radiation and surgery refractory meningiomas.
J Neurooncol. 2014 Mar;117(1):93-101. doi: 10.1007/s11060-014-1358-9.

Baldock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K,
Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK,
Silbergeld DL, Lai A, Cloughesy T, McKhann GM 2nd, Bruce JN, Rostomily RC, Canoll
P, Swanson KR. Patient-specific metrics of invasiveness reveal significant
prognostic benefit of resection in a predictable subset of gliomas. PLoS One.
2014 Oct 28;9(10):e99057.

Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA,
Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC,
Storer BE, Rockhill JK, Swanson KR, Kiem HP. Gene therapy enhances chemotherapy
tolerance and efficacy in glioblastoma patients. J Clin Invest. 2014

Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge
CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK,
Rockne RC, Swanson KR. Invasion and proliferation kinetics in enhancing gliomas
predict IDH1 mutation status. Neuro Oncol. 2014 Jun;16(6):779-86.
Chamberlain MC, Johnston SK. Salvage therapy with single agent bendamustine for recurrent glioblastoma. J Neurooncol. 2011 Dec;105(3):523-30.

Chamberlain MC, Johnston SK. Salvage therapy with single agent bevacizumab
for recurrent glioblastoma. J Neurooncol. 2010 Jan;96(2):259-69.

Johnston SK, Nguyen HQ, Wolpin S. Designing and testing a web-based interface
for self-monitoring of exercise and symptoms for older adults with chronic
obstructive pulmonary disease. Comput Inform Nurs. 2009 May-Jun;27(3):166-74.

Dougherty CM, Johnston SK, Thompson EA. Reliability and validity of the
self-efficacy expectations and outcome expectations after implantable
cardioverter defibrillator implantation scales. Appl Nurs Res. 2007

Parker JC, Smarr KL, Slaughter JR, Johnston SK, Priesmeyer ML, Hanson KD,
Johnson GE, Hewett JE, Hewett JE, Irvin WS, Komatireddy GR, Walker SE. Management
of depression in rheumatoid arthritis: a combined pharmacologic and
cognitive-behavioral approach. Arthritis Rheum. 2003 Dec 15;49(6):766-77.

Motzer SA, Tsuji J, Hertig V, Johnston SK, Scanlan J. Natural killer cell
cytotoxicity: a methods analysis of 51chromium release versus flow cytometry.
Biol Res Nurs. 2003 Oct;5(2):142-52.

Shaver JL, Johnston SK, Lentz MJ, Landis CA. Stress exposure, psychological
distress, and physiological stress activation in midlife women with insomnia.
Psychosom Med. 2002 Sep-Oct;64(5):793-802.

Johnston SK, Landis CA, Lentz MJ, Shaver JL. Self-reported nap behavior and
polysomnography at home in midlife women with and without insomnia. Sleep. 2001
Dec 15;24(8):913-9.

Jensen B, Hess-Zak A, Johnston SK, Otto DC, Tebbe L, Russell CL, Waller AS.
Restraint reduction: a new philosophy for a new millennium. J Nurs Adm. 1998
Jul-Aug;28(7-8):32-8. PubMed PMID: 9709694.



Johnston SK, Bridge CA, Rockne RC, Guyman L, Baldock AL, Rockhill JK, Mrugala MM, Beard BC, Adair JE, Kiem HP, Swanson KR. Enabling the Detection of Treatment Benefit through Patient-Specific Mathematical

Modeling:  Analysis of  Chemoprotective Hematopoietic Stem Cell Gene Therapy in Glioblastomas.  Proceeding of the Society for Neuro-Oncology 17th Annual Meeting, Washington, DC. November 15-18, 2012. Poster Presentation.  Neuro-Oncology, Volume 14 suppl 6 October 2012, NO-69.

Neuro Oncol (2012) 14(suppl 6): vi129-vi132 doi:10.1093/neuonc/nos237,  Baldock A, Yagle K, Ahn S, Johnston S, Mrugala M, Rockhill J, Born D, Swanson P, Trister A, Rockne R, Swanson KR. Invasion and Proliferation Kinetics Predict IDH-1 Mutation in Contrast-Enhancing Gliomas. Proceeding of the Society for Neuro-Oncology 17th Annual Meeting, Washington, DC. November 15-18, 2012. Podium Presentation. RB-14 Neuro Oncol (2012) 14(suppl 6): vi129-vi132 doi:10.1093/neuonc/nos237

Characteristics of long-term survivors in glioblastoma. Carly A  Bridge,  Anne Baldock, Priya Kumther, Paul  Dilfer, Sandra K Johnston, Joshua Jacobs, David Corwin, Laura Guyman, Russell Rockne, Adam Sonabend, Michael Cloney, Peter Canoll, Kristin R Swanson. For presentation at SNO 2013

Patient-specific mathematical modeling as a precision-medicine approach to evaluating therapeutic gains of a novel chemoprotection treatment in newly diagnosed glioblastoma. Sandra K. Johnston, Jennifer E. Adair, Carly Bridge, Laura Guyman, Andrea Hawkins-Daarud, Russell Rockne, Anne Baldock, Jason K. Rockhill, Maciej M. Mrugala, Brian C. Beard, Hans-Peter Kiem, Kristin Swanson. J Clin Oncol 31, 2013 (suppl; abstr e13041).